ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

CMS to delay final rule publication for oncology.

October 31, 2003